UCI Health psychiatrist honored for cognitive neuroscience research
Dr. Cameron S. Carter one of six scientists recognized in the Brain & Behavior Research Foundation Awards
October 21, 2024
Dr. Cameron S. Carter's clinical interest lies in the early diagnosis and treatment of neurodevelopmental disorders.
Orange, Calif. — UCI Health psychiatrist Dr. Cameron S. Carter has been awarded the 2024 Goldman-Rakic Prize for Outstanding Achievement in Cognitive Neuroscience Research by the Brain & Behavior Research Foundation's (BBRF) Scientific Council.
Carter will accept the award on Oct. 25 in New York City during the BBRF 2024 International Mental Health Research Symposium, where he will also give a presentation titled "A cognitive neuroscience approach to understanding circuits and symptoms in psychosis."
Created in 2003, the award celebrates excellence in neurobiological research at the cellular, physiological and/or behavioral levels that may advance the understanding of neurological or psychiatric conditions.
It honors the legacy of the late Patricia Goldman-Rakic, PhD, a Yale University neuroscientist who pioneered multidisciplinary research on the brain's frontal lobe and its role in cognitive processes.
"It is a great honor to be a part of this continued journey of discovery in understanding the human brain and its functions in health and in mental health disorders," said Carter.
Carter, Distinguished Professor and chair of the UC Irvine School of Medicine Department of Psychiatry & Human Behavior, will receive a $40,000 award and give an honorary lecture at Yale University in memory of Goldman-Rakic’s significant contributions.
BBRF is the largest private funder of mental health research grants dedicated to alleviating the suffering caused by mental illness through awards that encourage scientific advances and breakthroughs.
Carter's clinical interest lies in the early diagnosis and treatment of neurodevelopmental disorders. His research focused understanding on the neural basis of healthy cognition and the functional and biochemical changes in the body that underlie alterations in cognitive and emotional processing in conditions such as schizophrenia, bipolar disorder and autism.
His pioneering research seeks to advance the understanding of the underlying causes of these disorders and develop new therapies to improve patient outcomes, using leading-edge neuroimaging and electrophysiological technologies.
“We celebrate the Outstanding Achievement prizewinners and acknowledge the importance of neuroscience and psychiatric research to transform the lives of people living with mental illness,” said Jeffrey Borenstein, MD, president & CEO of the Brain & Behavior Research Foundation.
“These extraordinary scientists are advancing the development of new treatments, cures and methods of prevention for mental illness. We applaud them, and we thank our philanthropic supporters whose generosity allows us to continue to support the most promising research in the field of neuropsychiatry.”
Related stories
About UCI Health
UCI Health, one of California’s largest academic health systems, is the clinical enterprise of the University of California, Irvine. The system comprises its main campus UCI Medical Center, a 459-bed, acute care hospital in Orange, Calif., four hospitals and affiliated physicians of the UCI Health Community Network in Orange and Los Angeles counties and ambulatory care centers across the region. Recognized as a Top Hospital by The Leapfrog Group, UCI Medical Center provides tertiary and quaternary care and is home to Orange County’s only National Cancer Institute-designated comprehensive cancer center, high-risk perinatal/neonatal program and American College of Surgeons-verified Level I adult and Level II pediatric trauma center, gold level 1 geriatric emergency department and regional burn center. UCI Health serves a region of nearly 4 million people in Orange County, western Riverside County and southeast Los Angeles County. Follow us on Facebook, Instagram, LinkedIn and Twitter.
